Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice
Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Joost P.H. Drenth(Amsterdam Neuroscience), Frank Hoentjen(Radboud University Nijmegen), Wietske Kievit(Radboud University Nijmegen), Kim M. Gijsbers(Radboud University Nijmegen)
Cited by 17
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698